Gynecologic and Reproductive Health Concerns of Adolescents Using Selected Psychotropic Medications

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Psychiatric disorders are common in adolescent girls and may require chronic therapies with psychotropic medications. Antipsychotic medications and mood stabilizers have been increasingly prescribed to and widely used by adolescents for a variety of both " on" an " off" label indications. Studies on the safety and monitoring of these medications in adolescent girls have shown important potential for gynecologic and reproductive adverse effects. The objective of this article is to review the mechanisms for and management of menstrual disorders mediated by hyperprolactinemia associated with antipsychotic medications, hypothyroidism associated with lithium and quetiapine, and the independent association of polycystic ovary syndrome (PCOS) in girls using valproic acid. Beyond their susceptibility to these disruptions in the menstrual cycle, adolescent girls with psychiatric illness also have increased sexual risk behaviors. These behaviors makes it all the more important to review teratogenicity and clinically relevant contraceptive drug interactions in adolescent girls using these psychotropic medications.

Original languageEnglish (US)
Pages (from-to)7-15
Number of pages9
JournalJournal of Pediatric and Adolescent Gynecology
Volume26
Issue number1
DOIs
StatePublished - Feb 2013

Fingerprint

Reproductive Health
Antipsychotic Agents
Psychiatry
Hyperprolactinemia
Polycystic Ovary Syndrome
Valproic Acid
Menstrual Cycle
Contraceptive Agents
Risk-Taking
Hypothyroidism
Drug Interactions
Lithium
Sexual Behavior
Safety

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Pediatrics, Perinatology, and Child Health

Cite this

@article{8b937f77131f411db6f539e7b1e7e9cc,
title = "Gynecologic and Reproductive Health Concerns of Adolescents Using Selected Psychotropic Medications",
abstract = "Psychiatric disorders are common in adolescent girls and may require chronic therapies with psychotropic medications. Antipsychotic medications and mood stabilizers have been increasingly prescribed to and widely used by adolescents for a variety of both {"} on{"} an {"} off{"} label indications. Studies on the safety and monitoring of these medications in adolescent girls have shown important potential for gynecologic and reproductive adverse effects. The objective of this article is to review the mechanisms for and management of menstrual disorders mediated by hyperprolactinemia associated with antipsychotic medications, hypothyroidism associated with lithium and quetiapine, and the independent association of polycystic ovary syndrome (PCOS) in girls using valproic acid. Beyond their susceptibility to these disruptions in the menstrual cycle, adolescent girls with psychiatric illness also have increased sexual risk behaviors. These behaviors makes it all the more important to review teratogenicity and clinically relevant contraceptive drug interactions in adolescent girls using these psychotropic medications.",
author = "Talib, {Hina J.} and Alderman, {Elizabeth M.}",
year = "2013",
month = "2",
doi = "10.1016/j.jpag.2012.05.011",
language = "English (US)",
volume = "26",
pages = "7--15",
journal = "Journal of Pediatric and Adolescent Gynecology",
issn = "1083-3188",
publisher = "Elsevier USA",
number = "1",

}

TY - JOUR

T1 - Gynecologic and Reproductive Health Concerns of Adolescents Using Selected Psychotropic Medications

AU - Talib, Hina J.

AU - Alderman, Elizabeth M.

PY - 2013/2

Y1 - 2013/2

N2 - Psychiatric disorders are common in adolescent girls and may require chronic therapies with psychotropic medications. Antipsychotic medications and mood stabilizers have been increasingly prescribed to and widely used by adolescents for a variety of both " on" an " off" label indications. Studies on the safety and monitoring of these medications in adolescent girls have shown important potential for gynecologic and reproductive adverse effects. The objective of this article is to review the mechanisms for and management of menstrual disorders mediated by hyperprolactinemia associated with antipsychotic medications, hypothyroidism associated with lithium and quetiapine, and the independent association of polycystic ovary syndrome (PCOS) in girls using valproic acid. Beyond their susceptibility to these disruptions in the menstrual cycle, adolescent girls with psychiatric illness also have increased sexual risk behaviors. These behaviors makes it all the more important to review teratogenicity and clinically relevant contraceptive drug interactions in adolescent girls using these psychotropic medications.

AB - Psychiatric disorders are common in adolescent girls and may require chronic therapies with psychotropic medications. Antipsychotic medications and mood stabilizers have been increasingly prescribed to and widely used by adolescents for a variety of both " on" an " off" label indications. Studies on the safety and monitoring of these medications in adolescent girls have shown important potential for gynecologic and reproductive adverse effects. The objective of this article is to review the mechanisms for and management of menstrual disorders mediated by hyperprolactinemia associated with antipsychotic medications, hypothyroidism associated with lithium and quetiapine, and the independent association of polycystic ovary syndrome (PCOS) in girls using valproic acid. Beyond their susceptibility to these disruptions in the menstrual cycle, adolescent girls with psychiatric illness also have increased sexual risk behaviors. These behaviors makes it all the more important to review teratogenicity and clinically relevant contraceptive drug interactions in adolescent girls using these psychotropic medications.

UR - http://www.scopus.com/inward/record.url?scp=84872497239&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872497239&partnerID=8YFLogxK

U2 - 10.1016/j.jpag.2012.05.011

DO - 10.1016/j.jpag.2012.05.011

M3 - Article

VL - 26

SP - 7

EP - 15

JO - Journal of Pediatric and Adolescent Gynecology

JF - Journal of Pediatric and Adolescent Gynecology

SN - 1083-3188

IS - 1

ER -